Skip to main content
. 2019 May 13;18(1):792–803. doi: 10.3892/ol.2019.10348

Figure 6.

Figure 6.

Nuclear ERβ1 expression is not associated with the survival of patients with. (A) PFS and (B) OS were not significantly altered in patients with high ERβ1 expression compared with low expression. P=0.674; P=0.207, respectively. (C) PFS and (D) OS in patients with EGFR-mutant non-small cell lung cancer were not significantly altered in patients with high ERβ1 expression compared with low expression. P=0.519; P=0.342, respectively. Symbols represent censored observations. NSCLC, non-small cell lung cancer; PFS, progression free survival; OS, overall survival; ERβ1 estrogen receptor β1; EGFR, epidermal growth factor receptor.